Literature DB >> 12451434

Analysis of CYP2C9*5 in Caucasian, Oriental and black-African populations.

Umit Yasar1, Eleni Aklillu, Roberto Canaparo, Mia Sandberg, Jane Sayi, Hyung-Keun Roh, Agneta Wennerholm.   

Abstract

OBJECTIVE: CYP2C9 is a polymorphic gene with at least six known allelic variants (CYP2C9*1 to *6). CYP2C9*5 has been recently described in African-Americans. The lower activity of CYP2C9*5 encoded enzyme than *1 has been reported for the S-warfarin 7-hydroxylation in vitro. The aim of the present study was to develop an assay for the analysis of this variant and to determine the frequency of this polymorphism in different ethnic populations.
MATERIALS AND METHODS: A PCR-based endonuclease digestion method, using a mismatched forward primer that introduced a recognition site for AvaII in all the CYP2C9 genotypes except CYP2C9*5, is described. DNA samples from 150 Ethiopians, 183 Tanzanians, 200 Caucasians from Sweden and 150 Orientals from Korea were screened for this variant allele. RESULTS AND
CONCLUSION: The CYP2C9*5 allele was analysed using a polymerase chain reaction-based endonuclease method, and it was found in three Tanzanians (allele frequency, 0.0082) but not in Ethiopians, Caucasians or Orientals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12451434     DOI: 10.1007/s00228-002-0518-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  Allele and genotype frequencies of CYP2C9 in a Korean population.

Authors:  Jung-Woo Bae; Hyun-Kyung Kim; Ji-Hong Kim; Sang-In Yang; Mi-Jeong Kim; Choon-Gon Jang; Young-Seo Park; Seok-Yong Lee
Journal:  Br J Clin Pharmacol       Date:  2005-10       Impact factor: 4.335

2.  Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR.

Authors:  Faiza Yasmeen; Muhammad Bilal Ghafoor; Abdul Wadood Khalid; Waqas Latif; Shahida Mohsin; Shagufta Khaliq
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

3.  Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects.

Authors:  Aurel Constant Allabi; Yves Horsmans; Jean-Claude Alvarez; André Bigot; Roger K Verbeeck; Umit Yasar; Jean-Luc Gala
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-08-03       Impact factor: 2.441

4.  Evaluation of a reverse-hybridization StripAssay for the detection of genetic polymorphisms leading to acenocoumarol sensitivity.

Authors:  Argyri Gialeraki; Christos Markatos; Elisabeth Grouzi; Efrosyni Merkouri; Anthi Travlou; Marianna Politou
Journal:  Mol Biol Rep       Date:  2009-06-28       Impact factor: 2.316

Review 5.  Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals.

Authors:  Elena García-Martín; Carmen Martínez; José M Ladero; José A G Agúndez
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

Review 6.  Implementing genotype-guided antithrombotic therapy.

Authors:  Richard L Seip; Jorge Duconge; Gualberto Ruaño
Journal:  Future Cardiol       Date:  2010-05

7.  CYP2C9 genetic variants and losartan oxidation in a Turkish population.

Authors:  Melih O Babaoglu; Umit Yasar; Mia Sandberg; Erik Eliasson; Marja-Liisa Dahl; S Oguz Kayaalp; Atila Bozkurt
Journal:  Eur J Clin Pharmacol       Date:  2004-06-10       Impact factor: 2.953

Review 8.  Pharmacogenetics of oral anticoagulants: a basis for dose individualization.

Authors:  Simone Stehle; Julia Kirchheiner; Andreas Lazar; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

9.  Quantitative prediction of the impact of drug interactions and genetic polymorphisms on cytochrome P450 2C9 substrate exposure.

Authors:  Anne-Charlotte Castellan; Michel Tod; François Gueyffier; Mélanie Audars; Fredéric Cambriels; Behrouz Kassaï; Patrice Nony
Journal:  Clin Pharmacokinet       Date:  2013-03       Impact factor: 6.447

Review 10.  Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.

Authors:  Giorgio Sirugo; Branwen J Hennig; Adebowale A Adeyemo; Alice Matimba; Melanie J Newport; Muntaser E Ibrahim; Kelli K Ryckman; Alessandra Tacconelli; Renato Mariani-Costantini; Giuseppe Novelli; Himla Soodyall; Charles N Rotimi; Raj S Ramesar; Sarah A Tishkoff; Scott M Williams
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.